Minimal Change Disease

 MINIMAL CHANGE DISEASE 

Minimal change disease (MCD), or nil disease, is the most common cause of nephrotic syndrome in children under age 10. It accounts for about 90 percent of cases in children and about 10–15 percent in adult cases. Patients usually present with heavy proteinuria (>3 g/day), hypoalbuminemia, dyslipidemia, and anasarca. Urine sedi-ment is benign. Diagnosis rests on kidney biopsy. Under light microscopy, the glom-eruli appear normal. There is absence of immune deposits by immunofluorescence. Electron microscopic findings show efface-ment of the epithelial foot processes. Inves-tigators believe that MCD is a T-lymphocyte disease because of its sensitive response to steroids and cyclosporine. It is strongly associated with Hodgkin’s lymphoma, a hematologic malignancy. Proteinuria appears to disappear when the malignancy goes into remission. A glomerular perme-ability factor (GPF) derived from a T-cell hybridoma has been identified to cause fusion of the foot processes and protein-uria, when injected into experimental rats. The T-cell hybridoma was made from T cells harvested from a patient with minimal change disease. It is thought that this GPF has TNF-like activity. In addition, epithe-lial damage causes loss of polyanions like heparin sulfate. This loss of charge selectiv-ity allows macromolecules like albumin to pass through the filtration barrier and leak into the urine.

 

In children with idiopathic nephrotic syndrome, treatment with steroids produces immediate results with about 50 percent of cases going into remission in two weeks, and almost all within eight weeks of treatment. Clinical response in adults tends to be slower, but the majority will achieve remission after twelve to six-teen weeks of treatment. Cytotoxic agents, which include cyclophosphamide, chlo-rambucil, azathioprine, mycophenolate mofetil, and cyclosporine are reserved for relapsers and steroid-resistant cases.

Comments

Post a Comment

Popular posts from this blog

Tissue Damage Pathways: Hypersensitivity Reactions

TISSUE DAMAGE PATHWAYS Although the major function of the com-ponents of the immune system is to neu-tralize or destroy the invading organisms or antigen, these reactions often cause “bystander” tissue damage as well. These are called  hypersensitivity reactions , and Gell and Coombs conveniently divided them into five types. Hypersensitivity Reactions TYPE I: IMMEDIATE These reactions are those that involve antigens that react with IgE bound to tissue mast cells or basophils. Activation of the mast cell results in the release of large amounts of pharmacologically active sub-stances. These reactions are rapid (hence immediate) and if injected into the skin a “wheel and flare” reaction can be seen within five to ten minutes. Most anti-gens stimulating IgE are either inhaled or ingested. A perfect example of the inhaled antigen is ragweed pollen. The IgE pro-duction requires helper T cells and T-cell-derived cytokines. IL-4 and IL-13 stimulate IgE production while IFN- γ  is inh...
Read more

Specific Immune-Related Renal Diseases: IgA Nephropathy

  IgA Nephropathy   IgA nephropathy or Berger’s disease is the most common cause of glomerulonephritis in the world. Rarely seen in blacks, this dis-ease afflicts mainly Asians and Caucasians. Clinical features include gross hematuria (40–50 percent), microscopic hematuria (30–40 percent), and rarely, renal insuffi-ciency with edema and hypertension (less than 10 percent). These usually occur after a respiratory infection. Minimal protein-uria is noted. IgA nephropathy is made by kidney biopsy only. The hallmark of this disease is mesangial deposition of IgA, which is prominently noted on immuno-fluorescence. This deposition is associated with focal mesangial expansion, which can be seen on light microscopy. Electron microscopy confirms the presence of elec-tron-dense deposits in the mesangium, which correspond to the immune complex deposits. An abnormality in the regula-tion of IgA may exist because of an envi-ronmental stimuli. This is supported by higher circulating levels ...
Read more

Immunological Considerations of Transplantation

  IMMUNOLOGICAL CONSIDERATIONS  OF TRANSPLANTATION   The human major histocompatibility com-plex (MHC) comprises a set of genes on the short arm of chromosome 6. These genes are highly polymorphic and are codominantly expressed, each individual having inher-ited one set of MHC genes from each par-ent. MHC molecules present foreign anti-gens, as well as self-peptides, to T cells for recognition and response. In general, class I MHC molecules present peptides to CD8 +  T cells, while class II MHC molecules present peptides to CD4 +  T cells. In the context of transplantation, this process can determine acceptance or rejection of the donor graft.   Class I and II M HC loci carry the great-est significance for transplantation com-pared with other loci within the complex. While their polymorphisms are inherently critical to the species’ ability to resist various pathogens, these polymorphisms also pose one of the major obstacles to transplantation tolerance. Eve...
Read more